- Filed
- Oct 15, 2020 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2020 · Oct 7, 2020 | 3.8M sh |
| Shares Diluted | Q3 2020 · Aug 31, 2020 | 3.8M sh |
| Shares Diluted | Q3 2020 · Aug 31, 2020 | 3.8M sh |
| Shares Diluted | Q3 2020 · Aug 31, 2019 | 3.8M sh |
| Shares Diluted | Q3 2020 · Aug 31, 2019 | 3.8M sh |
| Operating Cash Flow | Q3 2020 · Aug 31, 2020 | −$12.8K |
| Operating Cash Flow | Q3 2020 · Aug 31, 2019 | −$31.24K |
| Cash And Equivalents | Q3 2020 · Aug 31, 2020 | $0 |
| Cash And Equivalents | Q3 2020 · Nov 30, 2019 | $5.1K |
| Cash And Equivalents | Q3 2020 · Aug 31, 2019 | $14.14K |
| Cash And Equivalents | Q3 2020 · Nov 30, 2018 | $33.39K |
| Stockholders Equity | Q3 2020 · Aug 31, 2020 | −$3K |
| Stockholders Equity | Q3 2020 · May 31, 2020 | −$37.65K |
| Stockholders Equity | Q3 2020 · Nov 30, 2019 | −$24.85K |
| Stockholders Equity | Q3 2020 · Aug 31, 2019 | −$15.81K |
| Stockholders Equity | Q3 2020 · May 31, 2019 | $5.25K |
| Stockholders Equity | Q3 2020 · Nov 30, 2018 | $14.23K |
| Current Liabilities | Q3 2020 · Aug 31, 2020 | $3K |
| Current Liabilities | Q3 2020 · Nov 30, 2019 | $29.96K |
| Total Liabilities | Q3 2020 · Aug 31, 2020 | $3K |
| Total Liabilities | Q3 2020 · Nov 30, 2019 | $29.96K |
| Current Assets | Q3 2020 · Aug 31, 2020 | $0 |
| Current Assets | Q3 2020 · Nov 30, 2019 | $5.1K |
| Total Assets | Q3 2020 · Aug 31, 2020 | $0 |
| Total Assets | Q3 2020 · Nov 30, 2019 | $5.1K |
| Sga Expense | Q3 2020 · Aug 31, 2020 | $3K |
| Sga Expense | Q3 2020 · Aug 31, 2020 | $15.79K |
| Sga Expense restated | Q3 2020 · Aug 31, 2019 | $21.07K |
| Sga Expense restated | Q3 2020 · Aug 31, 2019 | $30.04K |
| Net Income | Q3 2020 · Aug 31, 2020 | $34.65K |
| Net Income | Q3 2020 · Aug 31, 2020 | $21.86K |
| Net Income | Q3 2020 · Aug 31, 2019 | −$21.07K |
| Net Income | Q3 2020 · Aug 31, 2019 | −$30.04K |